These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 38572716)
1. Faecal Microbiota Transplantation Engraftment After Budesonide or Placebo in Patients With Active Ulcerative Colitis Using Pre-selected Donors: A Randomized Pilot Study. van Lingen E; Nooij S; Terveer EM; Crossette E; Prince AL; Bhattarai SK; Watson A; Galazzo G; Menon R; Szabady RL; Bucci V; Norman JM; van der Woude CJ; van der Marel S; Verspaget HW; van der Meulen-de Jong AE; Keller JJ J Crohns Colitis; 2024 Sep; 18(9):1381-1393. PubMed ID: 38572716 [TBL] [Abstract][Full Text] [Related]
2. Long-term efficacy and safety of monotherapy with a single fresh fecal microbiota transplant for recurrent active ulcerative colitis: a prospective randomized pilot study. Fang H; Fu L; Li X; Lu C; Su Y; Xiong K; Zhang L Microb Cell Fact; 2021 Jan; 20(1):18. PubMed ID: 33468164 [TBL] [Abstract][Full Text] [Related]
3. Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: a randomised placebo-controlled trial. Paramsothy S; Kamm MA; Kaakoush NO; Walsh AJ; van den Bogaerde J; Samuel D; Leong RWL; Connor S; Ng W; Paramsothy R; Xuan W; Lin E; Mitchell HM; Borody TJ Lancet; 2017 Mar; 389(10075):1218-1228. PubMed ID: 28214091 [TBL] [Abstract][Full Text] [Related]
4. Single Delivery of High-Diversity Fecal Microbiota Preparation by Colonoscopy Is Safe and Effective in Increasing Microbial Diversity in Active Ulcerative Colitis. Jacob V; Crawford C; Cohen-Mekelburg S; Viladomiu M; Putzel GG; Schneider Y; Chabouni F; OʼNeil S; Bosworth B; Woo V; Ajami NJ; Petrosino JF; Gerardin Y; Kassam Z; Smith M; Iliev ID; Sonnenberg GF; Artis D; Scherl E; Longman RS Inflamm Bowel Dis; 2017 Jun; 23(6):903-911. PubMed ID: 28445246 [TBL] [Abstract][Full Text] [Related]
5. Higher alpha diversity and Lactobacillus blooms are associated with better engraftment after fecal microbiota transplant in inflammatory bowel disease. Zhang YJ; Bousvaros A; Docktor M; Kaplan AL; Rufo PA; Leier M; Weatherly M; Zimmerman L; Nguyen LTT; Barton B; Russell G; Alm EJ; Kahn SA Sci Rep; 2024 Aug; 14(1):18188. PubMed ID: 39107366 [TBL] [Abstract][Full Text] [Related]
6. Specific Bacteria and Metabolites Associated With Response to Fecal Microbiota Transplantation in Patients With Ulcerative Colitis. Paramsothy S; Nielsen S; Kamm MA; Deshpande NP; Faith JJ; Clemente JC; Paramsothy R; Walsh AJ; van den Bogaerde J; Samuel D; Leong RWL; Connor S; Ng W; Lin E; Borody TJ; Wilkins MR; Colombel JF; Mitchell HM; Kaakoush NO Gastroenterology; 2019 Apr; 156(5):1440-1454.e2. PubMed ID: 30529583 [TBL] [Abstract][Full Text] [Related]
8. An Immunologic Compatibility Testing Was Not Useful for Donor Selection in Fecal Microbiota Transplantation for Ulcerative Colitis. Ponce-Alonso M; García-Hoz C; Halperin A; Nuño J; Nicolás P; Martínez-Pérez A; Ocaña J; García-Pérez JC; Guerrero A; López-Sanromán A; Cantón R; Roy G; Del Campo R Front Immunol; 2021; 12():683387. PubMed ID: 34149723 [TBL] [Abstract][Full Text] [Related]
9. STOP-Colitis pilot trial protocol: a prospective, open-label, randomised pilot study to assess two possible routes of faecal microbiota transplant delivery in patients with ulcerative colitis. Quraishi MNN; Yalchin M; Blackwell C; Segal J; Sharma N; Hawkey P; McCune V; Hart AL; Gaya D; Ives NJ; Magill L; Loi S; Hewitt C; Gerasimidis K; Loman NJ; Hansen R; McMullan C; Mathers J; Quince C; Crees N; Iqbal T BMJ Open; 2019 Nov; 9(11):e030659. PubMed ID: 31719078 [TBL] [Abstract][Full Text] [Related]
10. The taxonomic composition of the donor intestinal microbiota is a major factor influencing the efficacy of faecal microbiota transplantation in therapy refractory ulcerative colitis. Kump P; Wurm P; Gröchenig HP; Wenzl H; Petritsch W; Halwachs B; Wagner M; Stadlbauer V; Eherer A; Hoffmann KM; Deutschmann A; Reicht G; Reiter L; Slawitsch P; Gorkiewicz G; Högenauer C Aliment Pharmacol Ther; 2018 Jan; 47(1):67-77. PubMed ID: 29052237 [TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of single fecal microbiota transplantation for Japanese patients with mild to moderately active ulcerative colitis. Nishida A; Imaeda H; Ohno M; Inatomi O; Bamba S; Sugimoto M; Andoh A J Gastroenterol; 2017 Apr; 52(4):476-482. PubMed ID: 27730312 [TBL] [Abstract][Full Text] [Related]
12. A Matching Strategy To Guide Donor Selection for Ulcerative Colitis in Fecal Microbiota Transplantation: Meta-Analysis and Analytic Hierarchy Process. Zhang B; Yang L; Ning H; Cao M; Chen Z; Chen Q; Lian G; Tang H; Wang Q; Wang J; Lin Z; Wen J; Liu Y; Xuan J; Li X; Lin A; He J; Zhang L; Hou X; Zeng Q; Xiao C Microbiol Spectr; 2023 Feb; 11(1):e0215921. PubMed ID: 36472435 [TBL] [Abstract][Full Text] [Related]
13. Effect of Fecal Microbiota Transplantation on 8-Week Remission in Patients With Ulcerative Colitis: A Randomized Clinical Trial. Costello SP; Hughes PA; Waters O; Bryant RV; Vincent AD; Blatchford P; Katsikeros R; Makanyanga J; Campaniello MA; Mavrangelos C; Rosewarne CP; Bickley C; Peters C; Schoeman MN; Conlon MA; Roberts-Thomson IC; Andrews JM JAMA; 2019 Jan; 321(2):156-164. PubMed ID: 30644982 [TBL] [Abstract][Full Text] [Related]
14. Low Level Engraftment and Improvement following a Single Colonoscopic Administration of Fecal Microbiota to Patients with Ulcerative Colitis. Damman CJ; Brittnacher MJ; Westerhoff M; Hayden HS; Radey M; Hager KR; Marquis SR; Miller SI; Zisman TL PLoS One; 2015; 10(8):e0133925. PubMed ID: 26288277 [TBL] [Abstract][Full Text] [Related]
15. Longitudinal microbiome analysis of single donor fecal microbiota transplantation in patients with recurrent Clostridium difficile infection and/or ulcerative colitis. Mintz M; Khair S; Grewal S; LaComb JF; Park J; Channer B; Rajapakse R; Bucobo JC; Buscaglia JM; Monzur F; Chawla A; Yang J; Robertson CE; Frank DN; Li E PLoS One; 2018; 13(1):e0190997. PubMed ID: 29385143 [TBL] [Abstract][Full Text] [Related]
17. Changes in Intestinal Microbiota Following Combination Therapy with Fecal Microbial Transplantation and Antibiotics for Ulcerative Colitis. Ishikawa D; Sasaki T; Osada T; Kuwahara-Arai K; Haga K; Shibuya T; Hiramatsu K; Watanabe S Inflamm Bowel Dis; 2017 Jan; 23(1):116-125. PubMed ID: 27893543 [TBL] [Abstract][Full Text] [Related]
18. Role of Faecal Microbiota Transplantation for Maintenance of Remission in Patients With Ulcerative Colitis: A Pilot Study. Sood A; Mahajan R; Singh A; Midha V; Mehta V; Narang V; Singh T; Singh Pannu A J Crohns Colitis; 2019 Sep; 13(10):1311-1317. PubMed ID: 30873549 [TBL] [Abstract][Full Text] [Related]
19. Systematic review of donor and recipient predictive biomarkers of response to faecal microbiota transplantation in patients with ulcerative colitis. Rees NP; Shaheen W; Quince C; Tselepis C; Horniblow RD; Sharma N; Beggs AD; Iqbal TH; Quraishi MN EBioMedicine; 2022 Jul; 81():104088. PubMed ID: 35660786 [TBL] [Abstract][Full Text] [Related]
20. Findings From a Randomized Controlled Trial of Fecal Transplantation for Patients With Ulcerative Colitis. Rossen NG; Fuentes S; van der Spek MJ; Tijssen JG; Hartman JH; Duflou A; Löwenberg M; van den Brink GR; Mathus-Vliegen EM; de Vos WM; Zoetendal EG; D'Haens GR; Ponsioen CY Gastroenterology; 2015 Jul; 149(1):110-118.e4. PubMed ID: 25836986 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]